|
POMT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85309545486234E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.78209694065868E-11 |
| Normal-vs-Stage2 |
1.578160E-02 |
| Normal-vs-Stage3 |
5.71069969090843E-10 |
| Normal-vs-Stage4 |
2.73381317583699E-12 |
| Stage1-vs-Stage2 |
2.928000E-02 |
| Stage1-vs-Stage3 |
4.970800E-01 |
| Stage1-vs-Stage4 |
8.640400E-03 |
| Stage2-vs-Stage3 |
1.646170E-02 |
| Stage2-vs-Stage4 |
5.833300E-04 |
| Stage3-vs-Stage4 |
8.852300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27240004591067E-10 |
| Normal-vs-AfricanAmerican |
2.35299999999938E-05 |
| Normal-vs-Asian |
6.09369998905152E-10 |
| Caucasian-vs-AfricanAmerican |
9.533800E-01 |
| Caucasian-vs-Asian |
7.030200E-01 |
| AfricanAmerican-vs-Asian |
7.853600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28830000001301E-08 |
| Normal-vs-Female |
1.76270109619736E-11 |
| Male-vs-Female |
7.641000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04160013947308E-11 |
| Normal-vs-Age(41-60Yrs) |
2.91059998325238E-09 |
| Normal-vs-Age(61-80Yrs) |
7.57170000031948E-07 |
| Normal-vs-Age(81-100Yrs) |
5.460800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.190800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.652400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.047400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.439400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.974200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.253200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.61878999999088E-05 |
| Classical-VS-Follicular |
1.074400E-02 |
| Classical-VS-Other |
8.238600E-01 |
| Classical-VS-Normal |
2.9902746945254E-12 |
| Tall-VS-Follicular |
1.91980000008307E-07 |
| Tall-VS-Other |
3.995200E-01 |
| Tall-VS-Normal |
1.62669877568078E-12 |
| Follicular-VS-Other |
3.448200E-01 |
| Follicular-VS-Normal |
1.040050E-03 |
| Other-VS-Normal |
5.881900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.16140000020415E-07 |
| Normal-vs-N1 |
4.4619863359685E-13 |
| N0-vs-N1 |
1.417410E-04 |
|
|
